Trials / Terminated
TerminatedNCT02499185
Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients
A PILOT Study Evaluating Novel Biomarkers of AKI in Post-operative Patients Undergoing Major Intra-Abdominal Surgery
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To validate the use of \[TIMP-2\]●\[IGFBP-7\] to predict AKI in patients undergoing major intra abdominal surgery.
Detailed description
A prospective pilot single center study to investigate the potential of \[TIMP-2\].\[IGFBP-7\] to predict AKI (Acute Kidney Injury) in patients undergoing major abdominal surgery. The investigators will measure the biomarker once preoperatively and 4-times postoperatively starting at arrival on PACU (post anesthesia care unit).The primary endpoint of this study is the development of AKI stage 2 or 3 within the first 72 postoperative hours.
Conditions
- Acute Kidney Injury
- Arterial Hypertension
- Obesity
- Cardio Vascular Disease
- Diabetes Mellitus
- Chronic Liver Disease
- Hypercholesterolemia
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nephro Check Test | Urine sample |
| OTHER | serum creatinine measurement | Blood sample |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2017-07-31
- Completion
- 2017-08-31
- First posted
- 2015-07-16
- Last updated
- 2018-10-15
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02499185. Inclusion in this directory is not an endorsement.